8th Edition of World Congress on Infectious Diseases
June 09-11, 2025 | Rome, Italy
Research on Medicine and Vaccine for Covid-19
COVID-19 has claimed the lives of about 18 million people. Researchers are working around the clock to better understand, cure, and finally eradicate COVID-19 and the sickness that comes with it. WHO and its partners are dedicated to developing COVID-19 vaccines as quickly as possible while maintaining the highest safety requirements. Vaccines go through several stages of research and testing - clinical trials typically have three phases, the last of which is aimed to examine the product's capacity to protect against disease, known as effectiveness. Each phase evaluates the level of risk. Vaccines have previously been developed through a sequence of steps that can take years to complete. Given the critical need for COVID-19 vaccines, enormous financial investments and scientific collaborations are now transforming vaccine development.
- Antivirals
- Vaccines
- Clinical Trials
Francis J. Castellino
University of Notre Dame, United States
Stephen Hsu
Augusta University, United States
Ronald Desrosiers
University of Miami Miller School of Medicine, United States
Dong H Kwon
Long Island University, United States
Debra Hawkins
University of Oklahoma, United States
Pedro Plans Rubio
College of Physicians of Barcelona, Spain
Antonella Cardone
Cancer Patients Europe, BelgiumSubmit your abstract Today
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global climate change and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Impressive virologic suppression of SHIV infection with long-term AAV delivery of monoclonal antibodies
Ronald Desrosiers, University of Miami Miller School of Medicine, United States
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States